By Daniel Lawler
Paris, France -- An anti-Covid drug widely used across the world may have caused mutations in the virus, researchers said on Monday,...
The pandemic threw into stark focus, the challenges facing health care systems, from public health education, resourcing, and crisis preparedness. It introduced a new...
The Food and Drug Administration (FDA) has removed 48 online posts of the drug Molnupiravir for alleged unauthorized sale to the public.
FDA deputy director...
The Board of Investments said Monday it approved the registration of Lloyd Laboratories Inc. to locally manufacture globally-accepted COVID-19 therapy Molnupiravir.
Lloyd Laboratories Inc., a...
Study now enrolling participants in the Philippines who live in the same household as someone with symptomatic, laboratory-confirmed COVID-19
MSD, known as Merck & Co.,...
Presidential candidate Manila Mayor Isko Moreno Domagoso has offered anti-COVID-19 medicines to patients infected by the coronavirus and who are now in various hospitals...
Study now enrolling participants in the Philippines who live in the same household as someone with symptomatic, laboratory-confirmed COVID-19
MSD, known as Merck & Co.,...
RiteMed Philippines Inc. (RiteMed), in partnership with Faberco Life Sciences Inc., (Faberco), announced that it will start its distribution in the Philippines of the...
Molnupiravir, Merck & Co’s experimental antiviral pill against COVID-19, will be rolled out in the Philippines by November through hospitals with compassionate special permits...
Molnupiravir, the first oral antiviral drug clinically proven to reduce the risk of hospitalization or death from known COVID-19 variants by half, may be...
